** Brokerage Wells Fargo upgrades telemedicine firm American Well Corp to "overweight" from "equal weight"; maintains PT of $15
** Brokerage expects co's Converge platform to have been fully deployed with U.S. Defense Health Agency (DHA) by the end of Q4, implying it will generate revenue of a subscription model throughout 2025
** Co's Converge platform integrates in-person, virtual, and automated healthcare care into one system
** Brokerage says co's contract with DHA will generate $50 mln in revenue in 2025
** Brokerage believes AMWL's sales strategy pivot, led by incoming CFO Mark Hirschhorn, could lead to a more comprehensive "go-to-market strategy"
** Stock fell 75% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。